Detection of autoantibodies to livin and survivin in sera from lung cancer patients

Lung Cancer

Volumn 48, Issue 2, 2005, Pages 217-221

  Yagihashi, Atsuhito ^a   Asanuma, Koichi ^a   Kobayashi, Daisuke ^a   Tsuji, Naoki ^a   Shijubo, Yasuharu ^a   Abe, Shosaku ^a   Hirohashi, Yoshihiko ^a   Torigoe, Toshihiko ^a   Sato, Noriyuki ^a   Watanabe, Naoki ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Autoantibody; Livin; Lung cancer; Survivin

Indexed keywords

AUTOANTIBODY; LIVIN; PROTEIN; RECOMBINANT PROTEIN; SURVIVIN; UNCLASSIFIED DRUG;

ANTIBODY DETECTION; ANTIBODY RESPONSE; ARTICLE; BLOOD ANALYSIS; CANCER DIAGNOSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMORAL IMMUNITY; LUNG CANCER; PRIORITY JOURNAL;

EID: 20144387500     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2004.11.002     Document Type: Article

References (28)

1. F. Li Survivin study: what is next wave? J Cell Physiol 197 2003 8 29
2. G.M. Kasof, and B.C. Gomes Livin, a novel inhibitor of apoptosis protein family member J Biol Chem 276 2001 3238 3246
3. G. Ambrosini, C. Adida, and D.C. Altieri A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma Nat Med 3 1997 917 921
4. D. Vucic, H.R. Stennicke, M.T. Pisabarro, G.S. Salvesen, and V.M. Dixit ML-IAP, a novel inhibitor of apoptosis that is preferentially expressed in human melanomas Curr Biol 10 2000 1359 1366
5. J.H. Lin, G. Deng, Q. Huang, and J. Morser KIAP, a novel member of the inhibitor of apoptosis protein family Biochem Biophys Res Commun 279 2000 820 831
6. Y. Ashhab, A. Alian, A. Plliack, A. Panet, and D. Yehuda Two splicing variants of apoptosis gene with different biological properties and tissue distribution pattern FEBS Lett 495 2001 56 60
7. A.I. Sarela, R.C.A. Macadam, S.M. Farmery, A.F. Markham, and P.J. Guillou Expression of the antiapoptosis gene, survivin, predicts death from recurrent colorectal carcinoma Gut 46 2000 645 650
8. M. Nakamura, N. Tsuji, K. Asanuma, D. Kobayashi, A. Yagihashi, and K. Hirata Survivin as a predictor of cis-diamminedichloroplatinum sensitivity in gastric cancer patients Cancer Sci 95 2004 44 51
9. C.D. Lu, D.C. Altieri, and N. Tanigawa Expression of a novel antiapoptosis gene, survivin, correlated with tumor cell apoptosis and p53 accumulation in gastric carcinomas Cancer Res 58 1998 1808 1812
10. S. Nasu, A. Yagihashi, A. Izawa, K. Saito, K. Asanuma, and M. Nakamura Survivin mRNA expression in patients with breast cancer Anticancer Res 22 2002 1839 1843
11. P. Gazzaniga, A. Gradilone, O. Giuliani, I. Silvestri, I. Nofroni, and L. Frati Expression and prognostic significance of livin, survivin and other apoptosis-related genes in the progression of superficial bladder cancer Ann Oncol 14 2003 85 90
12. J.Y. Zhang, C.A. Casiano, X.X. Peng, J.A. Koziol, E.K.L. Chan, and E.M. Tan Enhancement of antibody detection in cancer using panel of recombinant tumor-associated antigens Cancer Epidemiol Biomarkers Prev 12 2003 136 143
13. A. James, J.Y. Zhang, C.A. Casiano, X.X. Peng, F.D. Shi, and A.C. Feng Recursive partitioning as an approach to selection of immune markers for tumor diagnosis Clin Cancer Res 9 2003 5120 5126
14. A. Yagihashi, K. Asanuma, M. Nakamura, J. Araya, Y. Mano, and T. Torigoe Detection of anti-survivin antibody in gastrointestinal cancer patients Clin Chem 47 2001 1729 1731
15. A. Yagihashi, K. Asanuma, N. Tsuji, T. Torigoe, N. Sato, and K. Hirata Detection of anti-livin antibody in gastrointestinal cancer patients Clin Chem 49 2003 1206 1208
16. J. Rohayem, P. Diestelkoetter, B. Weigle, A. Oehmichen, M. Schmitz, and J. Mehhorn Cancer Res 60 2000 1815 1817
17. M. Monzó, R. Rosell, E. Felip, J. Astudillo, J.J. Sánchez, and J. Maestre A novel anti-apoptosis gene: re-expression of survivin messenger RNA as a prognosis marker in non-small-cell lung cancers J Clin Oncol 17 1999 2100 2104
18. M. Ikehara, F. Oshita, Y. Kameda, H. Ito, N. Ohgane, and R. Suzuki Expression of survivin correlated with vessel invasion is a marker of poor prognosis in small adenocarcinoma of the lung Oncol Rep 9 2002 835 838
19. M. Falleni, C. Pellegrini, A. Marchetti, B. Oprandi, F. Buttitta, and F. Barassi Survivin gene expression in early-stage non-small cell lung cancer J Pathol 200 2003 620 626
20. H.S. Hofmann, A. Simm, A. Hammer, R.E. Silber, and B. Bartling Expression of inhibitors of apoptosis (IAP) proteins in non-small cell human lung cancer J Cancer Res Clin Oncol 128 2002 554 560
21. H. Tanabe, A. Yagihashi, N. Tsuji, Y. Shijubo, S. Abe, and N. Watanabe Expression of survivin mRNA and livin mRNA in non-small-cell lung cancer Lung Cancer 46 2004 299 304
22. M. Shmitz, P. Diestelkoetter, B. Weigle, F. Schmachtenberg, S. Stevanovic, and D. Ockert Generation of survivin-specific CD8+ T effector cells by dendritic cells pulsed with protein or selected peptides Cancer Res 60 2000 4845 4849
23. S. Reker, A. Meier, L. Holten-Anderson, I.M. Svane, J.C. Becker, and P. thor Straten Identification of novel survivn-derived CTL epitopes Cancer Biol Ther 3 2004 173 179
24. Y. Hirohashi, T. Torigoe, A. Maeda, Y. Nabeta, K. Kamiguchi, and T. Sato An HLA-A24-restricted cytotoxic T lymphocyte epitope of a tumor-associated protein, survivin Clin Cancer Res 8 2002 1731 1739
25. S. Reker, J.C. Becker, I.M. Svane, Ralfkaier, P. thor Straten, and M.H. Anderson HLA-B35-restricted immune responses against survivin in cancer patients Int J Cancer 108 2004 937 941
26. M.H. Anderson, S. Reker, J.C. Becker, and P. thor Straten The melanoma inhibitor of apoptosis protein: a target for spontaneous cytotoxic T cell responses J Invest Dermatol 122 2004 392 399
27. M.H. Anderson, J.C. Becker, and P. thor Straten Identification of an HLA-A3-restricted cytotoxic T lymphocyte (CTL) epitope from ML-IAP J Invest Dermatol 122 2004 1336 1337
28. J.C. Schmollinger, R.H. Vonderheide, K.M. Hoar, B. Maecker, J. Schultze, and F.S. Hodi Melanoma inhibitor of apoptosis protein (ML-IAP) is a target for immune-mediated tumor destruction Proc Natl Acad Sci USA 100 2003 3398 3403